Results of chemoselection with short induction chemotherapy followed by chemoradiation or surgery in the treatment of functionally inoperable carcinomas of the pharynx and larynx

Oral Oncology

Volumn 49, Issue 5, 2013, Pages 454-460

  Semrau, Sabine ^a   Schmidt, Daniela ^a   Lell, Michael ^a   Waldfahrer, Frank ^a   Lettmaier, Sebstian ^a   Kuwert, Torsten ^a   Iro, Heinrich ^a   Fietkau, Rainer ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Carcinoma of the larynx and hypopharynx; Chemoradiation; Chemoselection; Oral cancer; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; PACLITAXEL;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER CONTROL; CANCER SURGERY; CAUSE SPECIFIC SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DERMATITIS; DISEASE FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; INFECTION; LARYNX CARCINOMA; LEUKOPENIA; MALE; NECK DISSECTION; ORAL MUCOSITIS; ORGAN PRESERVATION; OVERALL SURVIVAL; PHARYNX CARCINOMA; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; ENDOSCOPY; FEASIBILITY STUDIES; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGAN SPARING TREATMENTS; PHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL RATE; TAXOIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875728129     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.12.008     Document Type: Article

References (20)

1. A.A. Forastiere, H. Goepfert, M. Maor, T.F. Pajak, R. Weber, and W. Morrison Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 22 2003 2091 2098 (Pubitemid 37464533)
2. P. Blanchard, B. Baujat, V. Holostenco, A. Bourredjem, C. Baey, and J. Bourhis Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumor site Radiother Oncol 100 1 2011 33 40
3. L. Van der Putten, R. De Bree, D.J. Kuik, D.H. Rietveld, J. Buter, and S.E. Eerenstein Salvage laryngectomy: oncological and functional outcome Oral Oncol 47 4 2011 296 301
4. K.P. Withrow, E.L. Rosenthal, C.G. Gourin, G.E. Peters, J.S. Magnuson, and D.J. Terris Free tissue transfer to manage salvage laryngectomy defects after organ preservation failure Laryngoscope 117 5 2007 781 784 (Pubitemid 46699343)
5. The Department of Veterans Affairs Laryngeal Cancer Study Group Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer N Engl J Med 324 24 1991 1685 1690
6. J.L. Lefebvre, D. Chevalier, B. Luboinski, A. Kirkpatrick, L. Collette, and T. Sahmoud Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group J Natl Cancer Inst 88 13 1996 890 899 (Pubitemid 26230640)
7. S. Urba, G. Wolf, A. Eisbruch, F. Worden, J. Lee, and C. Bradford Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm J Clin Oncol 24 4 2006 593 598 (Pubitemid 46630421)
8. J.B. Vermorken, E. Remenar, C. van Herpen, T. Gorlia, R. Mesia, and M. Degardin Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 17 2007 1695 1704 (Pubitemid 350005151)
9. M.R. Posner, D.M. Hershock, C.R. Blajman, E. Mickiewicz, E. Winquist, and V. Gorbounova Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 17 2007 1705 1715 (Pubitemid 350005152)
10. D. Citrin, J. Mansueti, A. Likhacheva, L. Sciuto, P.S. Albert, and S.F. Rudy Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 74 4 2009 1040 1046
11. M. Ekenel, S. Keskin, M. Basaran, C. Ozdemir, R. Meral, and M. Altun Induction chemotherapy with docetaxel and cisplatin is highly effective for locally advanced nasopharyngeal carcinoma Oral Oncol 47 7 2011 660 664
12. B. Berger, C. Belka, M. Weinmann, M. Bamberg, W. Budach, and T. Hehr Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol Strahlenther Onkol 186 5 2010 255 261
13. T. Kuhnt, A. Becker, M. Bloching, J. Schubert, G. Klautke, and R. Fietkau Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors Med Oncol 23 3 2006 325 333 (Pubitemid 44507141)
14. S. Semrau, F. Waldfahrer, M. Lell, R. Linke, G. Klautke, and T. Kuwert Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results Strahlenther Onkol 187 1 2011 15 22
15. J. Lefebvre, Y. Pointreau, F. Rolland, M. Alfonsi, A. Baudoux, and C. Sire Sequential chemoradiotherapy (SCRT) for larynx preservation (LP): results of the randomized phase II TREMPLIN study J Clin Oncol 2011 29 [suppl, abstr 5501]
16. Kikuchi M, Nakamoto Y, Shinohara S, Fujiwara K, Yamazaki H, Kanazawa Y, et al. Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma. Int J Clin Oncol 2012 March 9 [online first].
17. D.J. Sher, M.R. Posner, R.B. Tishler, N.J. Sarlis, R.I. Haddad, and E.J. Holupka Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324 Int J Radiat Oncol Biol Phys 81 5 2011 e813 e818
18. E. Ben-Josef, J. Moughan, J.A. Ajani, M. Flam, L. Gunderson, and J. Pollock Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11 J Clin Oncol 28 34 2010 5061 5066
19. D. De Ruysscher, M. Pijls-Johannesma, S.M. Bentzen, A. Minken, R. Wanders, and L. Lutgens Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer J Clin Oncol 24 7 2006 1057 1063 (Pubitemid 46638802)
20. X. Lu, X. Guo, M.H. Hong, Q.Y. Chen, Q. Zeng, and Y.Q. Xiang Comparison of the short-term efficacy of two inductive chemotherapy regimens for locally advanced nasopharyngeal carcinoma: docetaxel plus carboplatin versus 5-fluorouracil plus carboplatin Chin J Cancer 29 2 2010 140 144